Checkpoint Trend

  • Market Cap: Micro Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: INE396H01019
  • NSEID:
  • BSEID: 531099
INR
53.01
0.76 (1.45%)
BSENSE

Apr 13

BSE+NSE Vol: 53.01 k

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
{
  "main_header": {
    "sid": 510537,
    "name": "Checkpoint Trend",
    "stock_name": "Checkpoint Trend",
    "full_name": "Checkpoint Trends Ltd",
    "name_url": "stocks-analysis/checkpoint-trend",
    "exchange": 0,
    "exchangecode": "",
    "primexch": 0,
    "country_id": 34,
    "currency": "INR",
    "cmp": "53.01",
    "chg": 0.76,
    "chgp": "1.45%",
    "dir": 1,
    "prev_price": "52.25",
    "mcapval": "28.00 Cr",
    "mcap": "Micro Cap",
    "scripcode": 531099,
    "symbol": "",
    "ind_name": "Pharmaceuticals & Biotechnology",
    "ind_code": 4,
    "indexname": "India SENSEX",
    "isin": "INE396H01019",
    "curr_date": "Apr 13",
    "curr_time": "",
    "bse_nse_vol": "53.01 k",
    "exc_status": "Active",
    "traded_date": "Apr 13, 2026",
    "traded_date_str": "2026 04 13",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-register-score-header",
    "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/checkpoint-trend-510537-0&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0
    }
  },
  "news": {
    "results": [
      {
        "title": "Checkpoint Trends Ltd Upgraded to Hold as Technicals and Financials Improve",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/checkpoint-trends-ltd-upgraded-to-hold-as-technicals-and-financials-improve-3944144",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/4/CheckpointTrend_mojoScore_3944144.png",
        "date": "2026-04-13 08:09:00",
        "description": "Checkpoint Trends Ltd, a micro-cap player in the Pharmaceuticals & Biotechnology sector, has seen its investment rating upgraded from Sell to Hold as of 10 April 2026. This change reflects a combination of improved technical indicators, robust financial performance, attractive valuation metrics, and a positive quality assessment, signalling a cautious but optimistic outlook for investors."
      },
      {
        "title": "Checkpoint Trends Ltd Downgraded to Sell Amid Mixed Technicals and Valuation Concerns",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/checkpoint-trends-ltd-downgraded-to-sell-amid-mixed-technicals-and-valuation-concerns-3935722",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/4/CheckpointTrend_mojoScore_3935722.png",
        "date": "2026-04-07 08:18:26",
        "description": "Checkpoint Trends Ltd, a micro-cap player in the Pharmaceuticals & Biotechnology sector, has seen its investment rating downgraded from Hold to Sell as of 6 April 2026. This shift reflects a nuanced reassessment across four key parameters: quality, valuation, financial trend, and technicals, highlighting both strengths and emerging concerns in the company’s outlook."
      },
      {
        "title": "Checkpoint Trends Ltd Valuation Shifts to Very Attractive Amid Market Volatility",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/checkpoint-trends-ltd-valuation-shifts-to-very-attractive-amid-market-volatility-3868000",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/3/CheckpointTrend_valuationdot_3868000.png",
        "date": "2026-03-04 08:00:34",
        "description": "Checkpoint Trends Ltd has witnessed a significant shift in its valuation parameters, moving from an attractive to a very attractive rating, driven by improved price-to-earnings and price-to-book value metrics. This change comes amid a challenging market backdrop where the stock has underperformed the Sensex in the short term but continues to deliver exceptional long-term returns, prompting a reassessment of its price attractiveness relative to peers in the Pharmaceuticals & Biotechnology sector."
      },
      {
        "title": "Checkpoint Trends Ltd is Rated Hold by MarketsMOJO",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/checkpoint-trends-ltd-is-rated-hold-by-marketsmojo-3850337",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/2/CheckpointTrend_mojoScore_3850337.png",
        "date": "2026-02-22 10:10:41",
        "description": "Checkpoint Trends Ltd is rated 'Hold' by MarketsMOJO, with this rating last updated on 04 September 2025. However, the analysis and financial metrics discussed here reflect the stock's current position as of 23 February 2026, providing investors with an up-to-date view of the company’s fundamentals, returns, and market performance."
      },
      {
        "title": "Checkpoint Trends Ltd is Rated Hold by MarketsMOJO",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/checkpoint-trends-ltd-is-rated-hold-by-marketsmojo-3830386",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/2/CheckpointTrend_mojoScore_3830386.png",
        "date": "2026-02-10 10:11:11",
        "description": "Checkpoint Trends Ltd is rated 'Hold' by MarketsMOJO, with this rating last updated on 04 September 2025. However, the analysis and financial metrics discussed here reflect the company’s current position as of 10 February 2026, providing investors with the latest insights into its performance and outlook."
      },
      {
        "title": "Checkpoint Trends Ltd is Rated Hold",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/checkpoint-trends-ltd-is-rated-hold-3811150",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/1/CheckpointTrend_mojoScore_3811150.png",
        "date": "2026-01-30 10:10:35",
        "description": "Checkpoint Trends Ltd is rated 'Hold' by MarketsMOJO, a rating that was last updated on 04 September 2025. However, the analysis and financial metrics presented here reflect the company’s current position as of 30 January 2026, providing investors with an up-to-date view of the stock’s fundamentals, returns, and technical outlook."
      },
      {
        "title": "Are Checkpoint Trends Ltd latest results good or bad?",
        "link": "https://www.marketsmojo.com/news/result-analysis/are-checkpoint-trends-ltd-latest-results-good-or-bad-3810063",
        "imagepath": "",
        "date": "2026-01-29 19:20:20",
        "description": "Checkpoint Trends Ltd's latest financial results for Q3 FY26 present a complex picture characterized by significant revenue growth alongside notable profitability challenges. The company's net sales reached ₹174.09 crores, reflecting a sequential growth of 60.32% from the previous quarter, which is a substantial increase compared to the same period last year. This growth trajectory underscores the company's successful pivot from pharmaceutical manufacturing to trading operations, marking a remarkable year-on-year revenue increase of 173,990%.\n\nHowever, this revenue surge has not translated into improved profitability. The net profit for the quarter was ₹0.57 crores, representing a decline of 56.82% from the prior quarter's net profit of ₹1.32 crores. Additionally, the operating margin has contracted to 0.44%, down from 1.65% in Q2 FY26, indicating that the company is facing challenges in converting its sale..."
      },
      {
        "title": "Checkpoint Trends Q3 FY26: Explosive Revenue Surge Masks Wafer-Thin Margins in Trading Pivot",
        "link": "https://www.marketsmojo.com/news/result-analysis/checkpoint-trends-q3-fy26-explosive-revenue-surge-masks-wafer-thin-margins-in-trading-pivot-3808305",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/1/CheckpointTrend_quaterlyResult_3808305.png",
        "date": "2026-01-28 20:16:26",
        "description": "Checkpoint Trends Limited (formerly Rubra Medicaments Ltd.), a micro-cap pharmaceutical company with a market capitalisation of ₹66.00 crores, reported a net profit of ₹0.57 crores for Q3 FY26, marking a decline of 56.82% quarter-on-quarter but a turnaround from losses recorded in the corresponding quarter last year. The company's stock, trading at ₹123.95, has surged 1089.54% over the past year, reflecting extraordinary investor enthusiasm despite fundamental concerns about profitability and business model sustainability."
      },
      {
        "title": "When is the next results date for Checkpoint Trends Ltd?",
        "link": "https://www.marketsmojo.com/news/result-analysis/when-is-the-next-results-date-for-checkpoint-trends-ltd-3799025",
        "imagepath": "",
        "date": "2026-01-21 23:16:11",
        "description": "The next results date for Checkpoint Trends Ltd is scheduled for 28 January 2026...."
      }
    ],
    "total": 281,
    "sid": "510537",
    "stock_news_url": "https://www.marketsmojo.com/news/checkpoint-trends-510537"
  },
  "announcements": [
    {
      "caption": "Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018",
      "datetime": "09-Apr-2026",
      "details": "Compliance certificate for the quarter ended March 31 2026",
      "source": "BSE"
    },
    {
      "caption": "Closure of Trading Window",
      "datetime": "24-Mar-2026",
      "details": "Closure of trading window",
      "source": "BSE"
    },
    {
      "caption": "Board Meeting Outcome for Outcome Of Board Meeting",
      "datetime": "18-Mar-2026",
      "details": "Outcome of Board Meeting",
      "source": "BSE"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "<span>No</span> Upcoming Board Meetings",
      "data": []
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "No <strong>Dividend</strong> history available",
      "data": []
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "No <strong>Splits</strong> history available",
      "data": []
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "No <strong>Bonus</strong> history available",
      "data": []
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "No <strong>Rights</strong> history available",
      "data": []
    }
  ]
}
stock newsNews and Views
stock-recommendationAnnouncement

Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018

09-Apr-2026 | Source : BSE

Compliance certificate for the quarter ended March 31 2026

Closure of Trading Window

24-Mar-2026 | Source : BSE

Closure of trading window

Board Meeting Outcome for Outcome Of Board Meeting

18-Mar-2026 | Source : BSE

Outcome of Board Meeting

stock-recommendationCorporate Actions
Corporate Actions
info
stock-summary
BOARD MEETING

No Upcoming Board Meetings

stock-summary
DIVIDEND

No Dividend history available

stock-summary
SPLITS

No Splits history available

stock-summary
BONUS

No Bonus history available

stock-summary
RIGHTS

No Rights history available